Tenet Healthcare Corp. (THC) At $15.16 Forms Bottom; Ameritas Investment Partners Decreased Mednax (MD) Holding By $902,000

Tenet Healthcare Corp. (THC) formed multiple bottom with $14.40 target or 5.00% below today’s $15.16 share price. Tenet Healthcare Corp. (THC) has $1.53B valuation. The stock decreased 0.33% or $0.05 during the last trading session, reaching $15.16. About 1.33M shares traded. Tenet Healthcare Corp. (NYSE:THC) has declined 36.81% since January 1, 2017 and is downtrending. It has underperformed by 53.51% the S&P500.

Ameritas Investment Partners Inc decreased Mednax Inc (MD) stake by 42.58% reported in 2017Q3 SEC filing. Ameritas Investment Partners Inc sold 20,500 shares as Mednax Inc (MD)’s stock declined 21.94%. The Ameritas Investment Partners Inc holds 27,649 shares with $1.24 million value, down from 48,149 last quarter. Mednax Inc now has $4.95B valuation. The stock increased 0.15% or $0.08 during the last trading session, reaching $53.44. About 438,598 shares traded. MEDNAX, Inc. (NYSE:MD) has declined 18.20% since January 1, 2017 and is downtrending. It has underperformed by 34.90% the S&P500.

Among 17 analysts covering MEDNAX (NYSE:MD), 4 have Buy rating, 1 Sell and 12 Hold. Therefore 24% are positive. MEDNAX had 42 analyst reports since July 31, 2015 according to SRatingsIntel. Stifel Nicolaus maintained it with “Buy” rating and $76 target in Tuesday, March 8 report. The rating was maintained by Jefferies on Tuesday, April 11 with “Hold”. The stock of MEDNAX, Inc. (NYSE:MD) earned “Neutral” rating by Goldman Sachs on Friday, December 9. The stock of MEDNAX, Inc. (NYSE:MD) has “Overweight” rating given on Thursday, June 22 by Stephens. Raymond James downgraded the stock to “Mkt Perform” rating in Thursday, October 27 report. The stock has “Buy” rating by Mizuho on Wednesday, September 30. The firm has “Hold” rating by Zacks given on Monday, August 31. JP Morgan initiated the shares of MD in report on Wednesday, September 16 with “Overweight” rating. The stock has “Neutral” rating by Susquehanna on Monday, March 7. Jefferies maintained the shares of MD in report on Thursday, August 31 with “Hold” rating.

Ameritas Investment Partners Inc increased Vanguard Scottsdale Fds (VCIT) stake by 3,601 shares to 33,686 valued at $2.96 million in 2017Q3. It also upped Intuitive Surgical Inc (NASDAQ:ISRG) stake by 365 shares and now owns 4,276 shares. Halliburton Co (NYSE:HAL) was raised too.

Analysts await MEDNAX, Inc. (NYSE:MD) to report earnings on February, 6. They expect $0.79 EPS, down 16.84% or $0.16 from last year’s $0.95 per share. MD’s profit will be $73.23 million for 16.91 P/E if the $0.79 EPS becomes a reality. After $0.82 actual EPS reported by MEDNAX, Inc. for the previous quarter, Wall Street now forecasts -3.66% negative EPS growth.

Among 22 analysts covering Tenet Healthcare Corporation (NYSE:THC), 9 have Buy rating, 4 Sell and 9 Hold. Therefore 41% are positive. Tenet Healthcare Corporation had 70 analyst reports since July 21, 2015 according to SRatingsIntel. The stock of Tenet Healthcare Corp. (NYSE:THC) has “Underweight” rating given on Wednesday, December 20 by Morgan Stanley. The rating was maintained by Mizuho on Tuesday, December 19 with “Neutral”. The stock has “Buy” rating by Mizuho on Tuesday, January 19. BMO Capital Markets upgraded the shares of THC in report on Monday, August 31 to “Outperform” rating. The firm has “Mkt Perform” rating by Raymond James given on Thursday, November 10. Piper Jaffray maintained it with “Hold” rating and $1500 target in Tuesday, August 8 report. Piper Jaffray maintained it with “Hold” rating and $15.0 target in Monday, September 11 report. The company was downgraded on Wednesday, May 4 by Mizuho. On Monday, January 4 the stock rating was downgraded by Wells Fargo to “Market Perform”. The company was maintained on Wednesday, April 5 by Deutsche Bank.

Analysts await Tenet Healthcare Corp. (NYSE:THC) to report earnings on February, 26. They expect $1.29 EPS, up 2,050.00% or $1.23 from last year’s $0.06 per share. THC’s profit will be $130.19M for 2.94 P/E if the $1.29 EPS becomes a reality. After $-0.17 actual EPS reported by Tenet Healthcare Corp. for the previous quarter, Wall Street now forecasts -858.82% EPS growth.